Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Brown, Matthew E ^a   Rondon, Elizabeth ^a   Rajesh, Deepika ^a   Mack, Amanda ^a   Lewis, Rachel ^a   Feng, Xuezhu ^a   Zitur, Laura Jo ^a   Learish, Randall D ^a   Nuwaysir, Emile F ^a  

^a Cellular Dynamics International Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; DERIVATIZATION; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE REARRANGEMENT; GENETIC ANALYSIS; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; KARYOTYPE; MALE; MINIMALLY INVASIVE PROCEDURE; NERVE CELL; NUCLEAR REPROGRAMMING; PERIPHERAL LYMPHOCYTE; PLURIPOTENT STEM CELL; T LYMPHOCYTE; CELL DEDIFFERENTIATION; CELL LINE; CYTOLOGY;

ADULT; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL LINE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MALE; T-LYMPHOCYTES;

EID: 77955332631     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011373     Document Type: Article

References (30)

1. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
2. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
3. Loh YH, Agarwal S, Park IH, Urbach A, Huo H, et al. (2009) Generation of induced pluripotent stem cells from human blood. Blood 113: 5476-5479.
4. Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, et al. (2008) Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26: 1276-1284.
5. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, et al. (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science 324: 797-801.
6. Zhou H, Wu S, Joo JY, Zhu S, Han DW, et al. (2009) Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4: 381-384.
7. Maherali N, Hochedlinger K (2008) Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 3: 595-605.
8. Kleeberger CA, Lyles RH, Margolick JB, Rinaldo CR, Phair JP, et al. (1999) Viability and recovery of peripheral blood mononuclear cells cryopreserved for up to 12 years in a multicenter study. Clin Diagn Lab Immunol 6: 14-19.
9. Ye Z, Zhan H, Mali P, Dowey S, Williams DM, et al. (2009) Human induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood.
10. Saito H, Kato A, Matsumoto K, Okayama Y (2006) Culture of human mast cells from peripheral blood progenitors. Nat Protoc 1: 2178-2183.
11. Appelbaum FR, Thomas ED (2009) Thomas' hematopoietic cell transplantation: stem cell transplantation. Chichester, UK; Hoboken, NJ: Wiley-Blackwell xxx: 1718. [1732] p. of plates p.
12. Lichtman MA, Williams WJ (2006) Williams hematology. New York: McGraw-Hill Medical Pub;Division. 1 v. (various pagings), [48] p. of plates p.
13. Johnson LA, Morgan RA, Dudley ME, Cassard L, Yang JC, et al. (2009) Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood 114: 535-546.
14. Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, et al. (2006) Cancer regression in patients after transfer of genetically engineered lympho-cytes. Science 314: 126-129.
15. Mitchell RS, Beitzel BF, Schroder AR, Shinn P, Chen H, et al. (2004) Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2: E234.
16. van Lent AU, Nagasawa M, van Loenen MM, Schotte R, Schumacher TN, et al. (2007) Functional human antigen-specific T cells produced in vitro using retroviral T cell receptor transfer into hematopoietic progenitors. J Immunol 179: 4959-4968.
17. Hanna J, Markoulaki S, Schorderet P, Carey BW, Beard C, et al. (2008) Direct reprogramming of terminally differentiated mature B lymphocytes to pluripo-tency. Cell 133: 250-264.
18. Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, et al. (2009) Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460: 1132-1135.
19. Li H, Collado M, Villasante A, Strati K, Ortega S, et al. (2009) The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460: 1136-1139.
20. Marion RM, Strati K, Li H, Murga M, Blanco R, et al. (2009) A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460: 1149-1153.
21. Kawamura T, Suzuki J, Wang YV, Menendez S, Morera LB, et al. (2009) Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460: 1140-1144.
22. Utikal J, Polo JM, Stadtfeld M, Maherali N, Kulalert W, et al. (2009) Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 460: 1145-1148.
23. Eminli S, Foudi A, Stadtfeld M, Maherali N, Ahfeldt T, et al. (2009) Differentiation stage determines potential of hematopoietic cells for reprogram-ming into induced pluripotent stem cells. Nat Genet 41: 968-976.
24. Ludwig TE, Bergendahl V, Levenstein ME, Yu J, Probasco MD, et al. (2006) Feeder-independent culture of human embryonic stem cells. Nat Methods 3: 637-646.
25. Chatenoud L (2005) CD3-specific antibodies restore self-tolerance: mechanisms and clinical applications. Curr Opin Immunol 17: 632-637.
26. Berger C, Blau CA, Clackson T, Riddell SR, Heimfeld S (2003) CD28 costimulation and immunoaffinity-based selection efficiently generate primary gene-modified T cells for adoptive immunotherapy. Blood 101: 476-484.
27. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147.
28. van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, et al. (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.Leukemia 17: 2257-2317.
29. Ebert AD, Yu J, Rose FF, Jr., Mattis VB, Lorson CL, et al. (2009) Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457: 277-280.
30. Zhang SC, Wernig M, Duncan ID, Brustle O, Thomson JA (2001) In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 19: 1129-1133.